Fig. 4From: Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) studyMiRNAs demonstrating significantly different expression according to estrogen receptor status. The scatterplots show the expression of miRNAs in estrogen receptor positive and estrogen receptor negative breast cancers. Mean, standard deviation and false discovery rate (FDR) adjusted p-values are presentedBack to article page